Screener
Eligibility screening
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
10 US sites in CA, FL, MI, NM +5
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
10 US sites in CA, FL, MI, NM +5
Before we begin
Your answer affects how the questions are phrased.